Corrigendum to “N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression”[Eur. J. Med. Chem. 2020 Jan 1;185:111725] (European Journal of Medicinal Chemistry (2020) 185, (S0223523419308773), (10.1016/j.ejmech.2019.111725))

Samir Mehndiratta; Mei Hsiang Lin; Yi Wen Wu; Chun Han Chen; Tung Yun Wu; Kuo Hsiang Chuang; Min Wu Chao; Yi Ying Chen; Shiow Lin Pan; Mei Chuan Chen; Jing Ping Liou

doi:10.1016/j.ejmech.2020.112406

Corrigendum to “N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression”[Eur. J. Med. Chem. 2020 Jan 1;185:111725] (European Journal of Medicinal Chemistry (2020) 185, (S0223523419308773), (10.1016/j.ejmech.2019.111725))

Samir Mehndiratta, Mei Hsiang Lin, Yi Wen Wu, Chun Han Chen, Tung Yun Wu, Kuo Hsiang Chuang, Min Wu Chao, Yi Ying Chen, Shiow Lin Pan, Mei Chuan Chen, Jing Ping Liou

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

1 引文斯高帕斯（Scopus）

摘要

The authors regret that the information of the second corresponding author (M.-C. Chen) in the affiliation and the footnote of pdf version was misplaced. The correct version should be: Mei-Chuan Chena,h∗∗ h Ph.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taiwan. ∗∗Corresponding author. Ph.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taiwan. The authors would like to apologise for any inconvenience caused

原文	英語
文章編號	112406
期刊	European Journal of Medicinal Chemistry
卷	199
DOIs	https://doi.org/10.1016/j.ejmech.2020.112406
出版狀態	已發佈 - 8月 1 2020

ASJC Scopus subject areas

藥理
藥物發現
有機化學

存取文件

10.1016/j.ejmech.2020.112406

其它文件與鏈接

Link to publication in Scopus

指紋

深入研究「Corrigendum to “N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression”[Eur. J. Med. Chem. 2020 Jan 1;185:111725] (European Journal of Medicinal Chemistry (2020) 185, (S0223523419308773), (10.1016/j.ejmech.2019.111725))」主題。共同形成了獨特的指紋。

引用此

Mehndiratta, S., Lin, M. H., Wu, Y. W., Chen, C. H., Wu, T. Y., Chuang, K. H., Chao, M. W., Chen, Y. Y., Pan, S. L., Chen, M. C., & Liou, J. P. (2020). Corrigendum to “N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression”[Eur. J. Med. Chem. 2020 Jan 1;185:111725] (European Journal of Medicinal Chemistry (2020) 185, (S0223523419308773), (10.1016/j.ejmech.2019.111725)). European Journal of Medicinal Chemistry, 199, [112406]. https://doi.org/10.1016/j.ejmech.2020.112406

Corrigendum to “N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression”[Eur. J. Med. Chem. 2020 Jan 1;185:111725] (European Journal of Medicinal Chemistry (2020) 185, (S0223523419308773), (10.1016/j.ejmech.2019.111725)). / Mehndiratta, Samir; Lin, Mei Hsiang; Wu, Yi Wen 等.

於: European Journal of Medicinal Chemistry, 卷 199, 112406, 01.08.2020.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

Mehndiratta, S, Lin, MH, Wu, YW, Chen, CH, Wu, TY, Chuang, KH, Chao, MW, Chen, YY, Pan, SL , Chen, MC & Liou, JP 2020, 'Corrigendum to “N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression”[Eur. J. Med. Chem. 2020 Jan 1;185:111725] (European Journal of Medicinal Chemistry (2020) 185, (S0223523419308773), (10.1016/j.ejmech.2019.111725))', European Journal of Medicinal Chemistry, 卷 199, 112406. https://doi.org/10.1016/j.ejmech.2020.112406

Mehndiratta S, Lin MH, Wu YW, Chen CH, Wu TY, Chuang KH 等. Corrigendum to “N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression”[Eur. J. Med. Chem. 2020 Jan 1;185:111725] (European Journal of Medicinal Chemistry (2020) 185, (S0223523419308773), (10.1016/j.ejmech.2019.111725)). European Journal of Medicinal Chemistry. 2020 8月 1;199. 112406. https://doi.org/10.1016/j.ejmech.2020.112406

Mehndiratta, Samir ; Lin, Mei Hsiang ; Wu, Yi Wen 等. / Corrigendum to “N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression”[Eur. J. Med. Chem. 2020 Jan 1;185:111725] (European Journal of Medicinal Chemistry (2020) 185, (S0223523419308773), (10.1016/j.ejmech.2019.111725)). 於: European Journal of Medicinal Chemistry. 2020 ; 卷 199.

@article{04275804a352479aa83f90739a7ae189,

title = "Corrigendum to “N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression”[Eur. J. Med. Chem. 2020 Jan 1;185:111725] (European Journal of Medicinal Chemistry (2020) 185, (S0223523419308773), (10.1016/j.ejmech.2019.111725))",

abstract = "The authors regret that the information of the second corresponding author (M.-C. Chen) in the affiliation and the footnote of pdf version was misplaced. The correct version should be: Mei-Chuan Chena,h∗∗ h Ph.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taiwan. ∗∗Corresponding author. Ph.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taiwan. The authors would like to apologise for any inconvenience caused.",

author = "Samir Mehndiratta and Lin, {Mei Hsiang} and Wu, {Yi Wen} and Chen, {Chun Han} and Wu, {Tung Yun} and Chuang, {Kuo Hsiang} and Chao, {Min Wu} and Chen, {Yi Ying} and Pan, {Shiow Lin} and Chen, {Mei Chuan} and Liou, {Jing Ping}",

year = "2020",

month = aug,

day = "1",

doi = "10.1016/j.ejmech.2020.112406",

language = "English",

volume = "199",

journal = "CHIM.THER.",

issn = "0223-5234",

publisher = "Elsevier Masson SAS",

}

TY - JOUR

T1 - Corrigendum to “N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression”[Eur. J. Med. Chem. 2020 Jan 1;185:111725] (European Journal of Medicinal Chemistry (2020) 185, (S0223523419308773), (10.1016/j.ejmech.2019.111725))

AU - Mehndiratta, Samir

AU - Lin, Mei Hsiang

AU - Wu, Yi Wen

AU - Chen, Chun Han

AU - Wu, Tung Yun

AU - Chuang, Kuo Hsiang

AU - Chao, Min Wu

AU - Chen, Yi Ying

AU - Pan, Shiow Lin

AU - Chen, Mei Chuan

AU - Liou, Jing Ping

PY - 2020/8/1

Y1 - 2020/8/1

N2 - The authors regret that the information of the second corresponding author (M.-C. Chen) in the affiliation and the footnote of pdf version was misplaced. The correct version should be: Mei-Chuan Chena,h∗∗ h Ph.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taiwan. ∗∗Corresponding author. Ph.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taiwan. The authors would like to apologise for any inconvenience caused.

AB - The authors regret that the information of the second corresponding author (M.-C. Chen) in the affiliation and the footnote of pdf version was misplaced. The correct version should be: Mei-Chuan Chena,h∗∗ h Ph.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taiwan. ∗∗Corresponding author. Ph.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taiwan. The authors would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85084347711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85084347711&partnerID=8YFLogxK

U2 - 10.1016/j.ejmech.2020.112406

DO - 10.1016/j.ejmech.2020.112406

M3 - Comment/debate

AN - SCOPUS:85084347711

VL - 199

JO - CHIM.THER.

JF - CHIM.THER.

SN - 0223-5234

M1 - 112406

ER -